Cresco Labs (STU:6CQ) Cyclically Adjusted PS Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6CQ Cresco Labs Inc STU:6CQ
44 GF Score
Price €0.63
GF Value €0.76
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs  (STU:6CQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cresco Labs Cyclically Adjusted PS Ratio Related Terms


Cresco Labs Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted PS Ratio Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.01 0.78 0.55 0.40 0.51

Cresco Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.55 0.51 0.37 0.00

STU:6CQ vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PS Ratio falls into.


STU:6CQ
44GF Score
Cresco Labs Inc STU:6CQ
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cresco Labs's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cresco Labs's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.319/333.9520*333.9520
=0.319

Current CPI (Jun. 2026) = 333.9520.

Cresco Labs Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 0.000 240.628 0.000
201610 0.000 241.729 0.000
201701 0.000 242.839 0.000
201704 0.000 244.524 0.000
201707 0.000 244.786 0.000
201710 0.000 246.663 0.000
201801 0.000 247.867 0.000
201804 0.000 250.546 0.000
201807 0.000 252.006 0.000
201810 0.000 252.885 0.000
201903 0.165 254.202 0.217
201906 0.233 256.143 0.304
201909 0.285 256.759 0.371
201912 0.284 256.974 0.369
202003 0.304 258.115 0.393
202006 0.406 257.797 0.526
202009 0.357 260.280 0.458
202012 0.606 260.474 0.777
202103 0.631 264.877 0.796
202106 0.670 271.696 0.824
202109 0.675 274.310 0.822
202112 0.688 278.802 0.824
202203 0.665 287.504 0.772
202206 0.697 296.311 0.786
202209 0.706 296.808 0.794
202212 0.623 296.797 0.701
202303 0.595 301.836 0.658
202306 0.582 305.109 0.637
202309 0.529 307.789 0.574
202312 0.509 306.746 0.554
202403 0.496 312.332 0.530
202406 0.497 314.175 0.528
202409 0.466 315.301 0.494
202412 0.483 315.605 0.511
202503 0.438 319.799 0.457
202506 0.400 322.561 0.414
202509 0.395 324.800 0.406
202512 0.383 324.054 0.395
202603 0.359 330.213 0.363
202606 0.319 333.952 0.319

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cresco Labs (STU:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.63 is trading 17.1% below its estimated GF Value™ of €0.76. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for STU:6CQ:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €0.76 vs. price of €0.63 (17.1% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the STU:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Other Exchanges CRLBF:USACL:Canada
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
44GF Score

Get the complete analysis for STU:6CQ

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.63
Price
€0.76
GF Value